Revolution Medicines (RVMD) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Revolution Medicines (RVMD) is Neutral.

The composite score behind that read is +0.06, weighing +0.13 of bullish evidence against -0.21 bearish.

Revolution Medicines last closed at $189.76, +0.87% on the session.

Against the IVW growth benchmark the position is +0.07% over the forecast window.

The read is built from 15 underlying insights — 7 bullish and 8 bearish.

Agreement across those insights is 53%.

Revolution Medicines has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Revolution Medicines in the 11th percentile on return on equity, where 100 is best.

Revolution Medicines is classified under Health Care / Biotechnology, with a market capitalisation of $40.32B.

StockMap tracks Revolution Medicines as the 9th largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Revolution Medicines ranks 64th of 381 in the group, against a group median of -0.08.